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Abstract 
Background: The World Health Organization (WHO) has developed Problem Management Plus (PM+), a 5-session, 
psychological intervention program delivered by trained non-specialist that addresses common mental disorders. The 
objectives of this study are to evaluate effectiveness and cost-effectiveness of PM+ in a specialized mental health care 
facility in Pakistan.
Methods: A single blind individual randomized controlled trial (RCT) will be carried out in the outpatient depart-
ment of a specialized mental healthcare facility in Rawalpindi, Pakistan. After informed consent, patients with high 
psychological distress (General Health Questionnaire-12 (score >2) and functional impairment (WHO Disability Assess-
ment Schedule 2.0 score >16) will be randomised to PM+ plus treatment as usual (n = 96) or TAU only (n = 96). The 
primary outcome is the psychological distress, measured by levels of anxiety and depression on the Hospital Anxiety 
and Depression Scale and improvement in functioning as measured by WHODAS at 20 weeks after baseline. Second-
ary outcomes include improvement in symptoms of depression, post-traumatic stress disorder, levels of social support 
and cost effectiveness evaluation. Qualitative interviews will be conducted to evaluate the process of implementing 
PM+ including barriers and facilitators in implementation and possibility of integration of PM+ program in special-
ized mental health care facilities in Pakistan.
Discussion: The results of this study will be helpful in evaluating the effectiveness of the approach of training non 
specialists, based in the specialized mental health care facilities in delivering evidence based psychological interven-
tions in the low resource settings.
Trial registration Australian New Zealand Clinical Trials Registry, ACTRN12616000381482. Registered Retrospectively on 
March 23, 2016
Keywords: Low resource settings, Psychotherapy, Low and middle income countries, Cognitive behavioural therapy, 
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Background
Promoting mental health and wellbeing universally and 
equitably is a key undertaking in the global sustainable 
development agenda. Access to care for mental health 
has been included as one of the indicators in the sustain-
able development goals [1, 2]. The treatment gap for com-
mon mental disorders in low middle income countries 
(LMICs) such as Pakistan is documented to be nearly 
90% [3–5]. Whatever care is available, is concentrated in 
few urban specialized healthcare facilities which largely 
consists of pharmacotherapy and unstructured psycho-
therapy, if at all available [6]. With scarcity of mental 
health specialists (psychiatrists and professionally trained 
and certified clinical psychologists),lack of manualized, 
evidence based, and culturally appropriate psychological 
interventions, it is not possible to provide care to a large 
proportion of patients who present with common mental 
disorders in the healthcare facilities [7, 8]. WHO mhGAP 
programme makes available evidence-based psychologi-
cal interventions for priority mental health conditions 
to be delivered by non-specialists in primary healthcare 
settings. mhGAP program implementation is ongoing in 
Pakistan. The specialized mental health facilities have a 
key role in bridging the treatment gap through the imple-
mentation of mhGAP programme in the Primary Health 
Care (PHC) system and by providing training, supervi-
sion and ongoing support to the non-specialists [8].
For the program to be sustainable and to bridge the 
treatment gap at scale, a trained workforce is needed in 
the specialized healthcare centres to supervise and sup-
port the delivery of psychological interventions in the 
primary health care settings and to deal with the ever-
growing burden of patients presenting with common 
mental disorders in the outpatients departments of spe-
cialized facilities. Cascaded training and supervision 
system supported by task shifting strategies (wherein 
less qualified mental healthcare staff such as counsellors, 
social workers, health workers provide psychological 
interventions to the patients under specialist supervision 
[4, 9]) has been shown to be effective in bridging gap for 
mental health in low resource settings [10, 11].
This study addresses the issue of making available evi-
dence-based psychological support by evaluating the 
effectiveness and cost-effectives of the implementing 
WHO Problem Management Plus (PM+) program in a 
specialized health care facility in Pakistan. PM+ is a trans-
diagnostic, low intensity psychological intervention for 
common mental disorders (e.g. depression, anxiety, stress), 
developed by WHO as part of its mhGAP Program.
Problem Management Plus has following four core 
features:
1. It is brief; consisting of five individual sessions
2. It can be delivered by specialists (psychiatrists, psy-
chologists) as well as trained non-specialists includ-
ing social workers, health workers and volunteers
3. The intervention is trans diagnostic-addressing 
depression, anxiety and stress and
4. It has been designed for use in low resource settings 
and especially those affected by chronic adversity 
(e.g. violence and humanitarian crises).
Problem Management Plus consists of problem-solving 
and behaviour therapies techniques (problem solving 
counselling plus stress management, behavioural activa-
tion and social support) that are empirically supported 
and formally recommended by the WHO [12–15].
Problem Management Plus has been culturally adapted 
for use in Pakistan (Chiumento et al., forthcoming) and 
tested for effectiveness in the primary healthcare and 
community settings of Pakistan where it was found effec-
tive in reducing symptoms of anxiety and depression [16, 
17].
The proposed study is aimed at evaluating the effective-
ness and cost-effectiveness of a psychological interven-
tion delivered by non-specialists based in the specialized 
mental health care facility of a resource poor setting, 
under the supervision of specialists.
Methods
Objectives and hypotheses
The overall aim of this randomized controlled trial (RCT) 
is to evaluate the effectiveness and cost-effectiveness of 
PM+ plus Treatment-as-Usual (TAU) compared to TAU 
only in the management of common mental disorders 
in a specialized mental healthcare facility in Rawalpindi, 
Pakistan.
The primary hypothesis is that PM+ plus treatment as 
usual is superior to TAU alone in reducing psychological 
distress (depression and anxiety) and improving func-
tioning at 20 weeks post assessment. Secondary hypoth-
eses are that:
1. Participants in the intervention arm will report 
reduced symptoms of depression, post-traumatic 
stress and PM+ intervention will result in improved 
levels of social support assessed at post-assessment 
at 7  weeks, and follow-up end-point assessments at 
20 weeks.
2. PM+ plus TAU is more cost effective than TAU 
alone in the management of common mental disor-
ders in a specialized mental health care facility.
Figure  1 presents an overview of the design. SPIRIT 
recommendations have been followed in preparing the 
trial protocol (Additional file 1: Appendix A).
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A qualitative component will explore the feasibility of 
setting up specialist PM+ clinics at specialized care facil-
ities in a LMIC such as Pakistan.
Setting and participants
The study will be carried out in the outpatient depart-
ment of a specialized mental health care facility in Raw-
alpindi, Pakistan. As the only tertiary mental health care 
facility, it caters to the mental health care needs of the 
population living in the northwest of Pakistan. It is affili-
ated with the medical school and universities in the city 
and provides undergraduate and postgraduate mental 
health research and training to both local and interna-
tional students.
The study will be conducted with adult walk-in cli-
ents presenting with common mental disorders such as 
depression, stress and anxiety related conditions. Inclu-
sion criteria are: (a) adult (age 18–60  years) outpatient 
department attendees, referred for psychotherapy for 
depression, anxiety and stress related conditions by the 
specialists after routine evaluation; (b) score above 2 
on a screening questionnaire for psychological distress 
(General Health Questionnaire-12; GHQ-12; [18, 19]) 
and (c) score above 16 on a screening questionnaire for 
functional impairments (WHO Disability Assessment 
Schedule 2.0; WHODAS; [20]). These instruments are 
described below. Exclusion criteria are: (a) acute medical 
conditions; (b) imminent suicide risk; (c), psychosis, alco-
hol or drug-use dependence; and (d) cognitive impair-
ment (e.g. severe intellectual disability, dementia).
Procedure
Individuals who present at the out-patients department 
will be evaluated for depression, anxiety, or other stress 
related mental health conditions by a psychiatrist. After 
clinical evaluation, if the psychiatrist decides psychother-
apy/psychosocial support is indicated, s/he will intro-
duce the PM+ study. If the person agrees to participate 
in the study, the participant will be referred to the study 
coordinator.
The study coordinator will seek written informed con-
sent for participation in the study. The informed consent 
procedure consists of two-steps: (1) Informed consent 
for screening and (2) Informed consent for the PM+ 
trial. The latter is only required for participants meeting 
inclusion criteria. For each step respondents who decide 
to participate will be asked to complete a written con-
sent form. Each individual will be given at least 24 h to 
decide to take part in the trial. Illiterate participants will 
be asked witnessed oral consent and a thumb print in lieu 
of a signature, in line with recommendations from WHO 
[21]. The witness will not be a member of the research 
team.
Next, the independent assessment team, trained in the 
ethical conduct of research and assessments, will conduct 
the screening and administer the GHQ-12 and WHO-
DAS. Participants meeting inclusion criteria (GHQ-
12  >2 and WHODAS  >16) will be randomised using 
computerized software on a 1:1 basis by an independ-
ent researcher not involved in the conduct of the study. 
The assessment team will record demographic informa-
tion and will administer the Psychological Outcome Pro-
files instrument (PSYCHLOPS), Hospital Anxiety and 
Depression Scale (HADS), Patient Health Questionnaire 
(PHQ-9), PTSD Checklist Civilian version (PCL-C), Life 
Events Checklist for Pakistan (LECFP), Harvard Trauma 
Questionnaire (HTQ) events list, Multidimensional Scale 
of Perceived Social Support (MSPSS) and the Client Ser-
vice Receipt Inventory (CSRI).
The post-intervention assessment (WHODAS, HADS, 
PHQ-9, PCL-C, MSPSS and PSYCHLOPS) will be sched-
uled at 7  weeks after the pre-intervention assessment 
(i.e. 1 week after the 5th PM+ session), and the follow-
up assessment (WHODAS, HADS, PHQ-9, PCL-C, 
PSYCHLOPS, MSPSS and CSRI) will be scheduled at 
13  weeks after the post-intervention assessment (i.e. 
20 weeks after inclusion, in line with the timing of the fol-
low-up assessment for the PM+ plus TAU participants). 
Fig. 1 Flow diagram
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Table 1 presents an overview of measures that are admin-
istered at each of the assessments.
Ongoing supervision of assessors will be conducted by 
the study coordinator. The assessment team will be blind 
to the allocation status of the participants.
Sample size and power calculations
Sample size calculation is based on a multicentre study 
of culturally-adapted cognitive behavioural therapy 
(CBT)-based intervention conducted in Pakistan that 
used HADS as the primary outcome measure [22]. A 
two-point reduction in HADS depression score between 
the intervention and control group is considered to be 
clinically relevant. With p < .05 and 90% power, a total of 
96 participants are needed. Accounting for an expected 
drop-out rate of 50%, the total sample size is 192 partici-
pants, who will be equally randomized to PM+ plus TAU 
(n = 96) and TAU only (n = 96).
The Problem Management Plus (PM+) program
Developed by the WHO, PM+ seeks to ameliorate symp-
toms of common mental health problems [23, 24]. PM+ 
is delivered over 5 weekly sessions with 90 min duration 
for each. The PM+ program is being made available in 
different formats, however, in the current RCT, the PM+ 
individual version will be tested.
Session one orients participants to the program with 
motivational interviewing techniques to improve engage-
ment, provides psychoeducation about common reac-
tions to adversity, and teaches participants a basic stress 
management strategy. The latter strategy is practiced at 
the conclusion of every subsequent session to enhance 
learning. Session two addresses a participant-selected 
problem through the provision of problem solving tech-
niques and introduces commencement of behavioural 
activation procedures. Sessions three and four continue 
to support participants’ application of problem solv-
ing, behavioural activation, and relaxation exercises, 
and introduces strategies to strengthen social support 
networks. In session five, education about retaining treat-
ment gains is given, all learned strategies are reviewed, 
and the program is finished.
Problem Management Plus providers will be trained 
therapists, who have received eight days training in 
PM+  by the master trainer. All the PM+  providers in 
this trial had a master’s degree (16  years of education) 
in psychology. The adherence of the PM+ protocol will 
be assured by completing a self-check for each session 
by the PM+ providers, supported by peer-supervision. 
Fidelity of intervention will be ensured by fortnightly 
supervisions with the master trainer through Skype.
Treatment‑as‑Usual (TAU)
Treatment-as-Usual in the outpatients department for 
individuals with common mental disorders usually con-
sists of an initial evaluation by trainee psychologists and 
psychiatrists followed by an expert consultation on the 
case. The main stay of treatment at specialized mental 
health care facilities is pharmacotherapy. Counselling 
and psychotherapy are frequently advised but lack of 
standardized training in psychotherapies and evidence 
base packages of care make the counselling non-specific 
and non-replicable. We will record complete details of 
the treatments accessed by the trial participants from 
both arms by using the adapted Client Services Receipt 
Inventory [25] at baseline and follow-up.
Screening measures
GHQ-12 [18, 19] assesses level of general psychological 
distress during screening. It consists of 12 questions that 
are scored on a four-point Likert scale ranging from 0 to 
3. When used as a screening tool, the GHQ-12 is usually 
scored bi-modally (i.e.-0,1), and the total score ranges 
between 0–12, with higher scores representing higher 
levels of distress. In previous studies in Pakistan, cut-offs 
of 1 or higher and 2 or higher have been reported and 
used for determining clinical caseness of common mental 
health disorders [19, 26, 27].
Table 1 Overview of instruments and assessments
Concept Pre-assessment measures Post-treatment assessment  
measures
3-months post-treatment 
follow-up assessment measures
Psychological distress GHQ-12 (screener)
Functioning WHODAS (screener,  
primary outcome)
WHODAS WHODAS
Mental disorders HADS (primary outcome) HADS (primary outcome) HADS (primary outcome)
PCL-C PCL-C PCL-C
PHQ-9 PHQ-9 PHQ-9
Perceived problems PSYCHLOPS PSYCHLOPS PSYCHLOPS
Adverse life events HTQ events list LELFP
Costs of care CSRI CSRI
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WHODAS [20] is a generic assessment instrument 
assessing health and disability. Simple to adminis-
ter, it is applicable across all health states, including 
mental disorders, and across cultures. The WHODAS 
assesses difficulties people have due to their illness 
across six domains of functioning (cognition, mobility, 
self-care, getting along, life activities, and participa-
tion). Difficulties are scored over the last 30 days on a 
five-point Likert scale as none, mild, moderate, severe, 
or extreme. The 12-item interviewer administered 
version translated in Urdu will be used in this study 
as a screener as well as one of the primary outcome 
measures.
Primary outcomes
Primary outcomes are (a) states of anxiety and depres-
sion measured using the HADS [28, 29]. The HADS is 
a well-established 14-item scale consisting of two sub-
scales: HADS-A (anxiety, seven items, range 0–21) and 
HADS-D (depression, seven items, range 0–21). Higher 
scores indicate more anxiety and/or depression. The 
Urdu version of the HADS showed satisfactory reliabil-
ity and validity [29] (b) Functional impairment assessed 
using the WHODAS (described above).
Secondary outcomes
The PHQ-9 is nine-item instrument measuring presence 
and severity of depression during the past 2 weeks [30]. 
The PHQ-9 questions are derived from the 16-item ver-
sion. Participants rate their responses on a four-point 
Likert scale ranging from “not at all” to “nearly every day”. 
The PHQ-9 total severity score ranges from 0 to 27. The 
PHQ has been validated in Urdu [31, 32].
DSM IV posttraumatic stress disorder (PTSD) symp-
toms during the past week will be measured using the 
17-item PCL-C [33]. Items are rated on a 1–5 scale and 
add up to a total severity score of 85. The PCL-C has 
been used previously in Pakistan [34] and has been found 
to have acceptable psychometric properties (Mushtaq, 
unpublished data, 2013). The PCL-C will be adapted to 
ask for symptoms in the last week (rather than month) to 
enhance sensitivity to change.
PSYCHLOPS [35] assesses progress on problems for 
which the person seeks help. It consists of four questions 
that encompass three domains: problems (2 questions), 
functioning (1 question) and wellbeing (1 question). Par-
ticipants are asked to give free text responses to the prob-
lem and function domains. Responses are scored on an 
ordinal six-point scale producing a maximum score of 20 
(6 points per domain). The PSYCHLOPs version admin-
istered at post-treatment and follow-up also includes 
an overall evaluation question (determining self-rated 
outcome ranging from “much better” to “much worse”). 
PSYCHLOPS has been validated in primary care popula-
tions across several countries [36, 37].
The MSPSS [38, 39] aims to measure perceived social 
support. It includes 12 items which cover three dimen-
sions: family, friends and significant others. Each item 
is rated on a seven-point Likert-scale (1 = very strongly 
disagree; 7 = very strongly agree). A total score is calcu-
lated by summing the results for all items (range 12–84) 
with higher scores indicating higher levels of perceived 
social support. The MSPSS has been validated in Urdu 
[39].
Cost‑effectiveness measures
Indicators of economic impact will be assessed using the 
WHODAS question on days out of role and the CSRI. 
The CSRI was developed for the collection of data on ser-
vice utilization and related characteristics of people with 
mental disorders, as the basis for calculating the costs of 
care for mental health cost-effectiveness research [25]. It 
has been previously used in Pakistan and India [40, 41].
Other measures
Data on socio-demographic information including sex, 
age, education, marital status and work status) will be 
collected.
To assess the experience of potentially traumatic 
events, part one of the HTQ [42] will be administered. 
This includes 17 items describing a range of traumatic 
events, such as: “lack of food and water”, “forced separa-
tion from family members”, and “being close to death”. 
Each event is rated as either present (1) or absent (0). The 
HTQ has been validated and applied in many countries, 
including Pakistan [43].
Life events other than potentially traumatic events 
(e.g. loss of job, housing problems, financial difficulties, 
problems with the law, marital problems, bereavement, 
etc.) are assessed using a life events measure previously 
developed for the Pakistani population (LECFP [44]). Life 
events are rated as either present (1) or absent (0).
Process evaluation
The feasibility, difficulties and successes in carrying out 
intervention activities will be explored through compre-
hensive process monitoring and semi-structured inter-
views with key stakeholders including PM+  providers, 
intervention recipients and clinical staff involved in the 
study.
Individual semi-structured interviews will be con-
ducted within 4  weeks after the conduct of final out-
come assessments with five participants from each 
category. The aim of these interviews is to explore their 
perceptions of the benefits and challenges of integrating 
PM+  into the routine service provision. Interviews will 
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follow a semi-structured interview guide including fol-
lowing topics: overall impressions of PM+, experiences 
of PM training and supervision, rapport with participants 
and families of participants, views on the delivery for-
mat, experiences of participants’ intervention adherence 
and strategies to keep participants motivated, view on 
intervention scalability and integration into the existing 
systems.
Qualitative interviews and data analysis will be con-
ducted by a pair of researchers independent of the 
research team to avoid any bias in responses. Researchers 
will be trained in qualitative interviewing and will be pro-
vided supervision throughout data collection and analy-
sis process by a senior researcher. All the interviews will 
be recorded and transcribed. Analysis will be conducted 
manually following a framework analysis approach.
Process monitoring includes the review of PM+  pro-
viders’ records of sessions with participants, PM+  pro-
viders’ supervision records including intervention fidelity 
monitoring and supervision of supervisors by the master 
trainer. This data will be collected throughout the inter-
vention delivery and reviewed as it is collected, leading to 
an iterative process of intervention monitoring informing 
intervention delivery.
Findings from this phase of the study will be used to 
inform the set-up of PM+  clinics at specialized mental 
health care facilities locally, nationally and internationally.
Analysis
Primary analyses will be based on intent-to-treat popula-
tion and secondary analyses will be based on per-proto-
col population.
The primary outcome will be summarised using num-
ber of subjects (n), means, standard deviations (SD), min-
imum, and maximum.
To estimate the treatment effect, a linear mixed model 
will be employed for the primary endpoint analysis, 
which will have treatment, as fixed effects, baseline meas-
urement of primary endpoint as covariate, and subject as 
random effects. The mean difference between two treat-
ment arms at each visit/time together with its 95% con-
fidence interval will be derived from the mixed model. 
Covariate-adjusted mixed model of primary endpoint 
will also be performed by adding pre-specified covariates 
at baseline into the above model.
The details of the analysis can be found in the attached 
Statistical Analysis Plan (SAP) (Additional file 2: Appen-
dix B).
Cost‑effectiveness analysis We will also analyse aggre-
gated health care costs, computed from costs of treat-
ment (primary care, outpatient hospital visits, inpatient 
admission, diagnostic tests and investigations, drug pre-
scriptions), and the aggregated patient and family costs 
(number of days with reduced working hours, informal 
caregiving time by relatives or friends), and travel costs 
and time spent travelling to or waiting for consultations. 
The between-group comparison of mean costs will be 
completed using a standard t test with ordinary least 
squares regression used for adjusted analyses, with the 
validity of results confirmed using bootstrapping.
Analyses of the data will be carried out in SPSS version 
21 and SAS 9.3. Across all analyses, two-tailed tests will 
be reported with p < .05.
Adverse events reporting
All adverse events (AEs) and serious adverse events 
(SAEs) reported spontaneously by the subject or 
observed by the investigators or other staff members will 
be recorded by the research team. We consider an event a 
SAE if it is an undesirable experience occurring to a sub-
ject during the study, whether or not considered related 
to the research procedure. Although it is unlikely that 
SAEs would occur given the nature of the intervention, 
all adverse events and SAEs will be reported to the local 
independent advisory board. The chair or a nominated 
person from the advisory board will review SAEs within 
48 h and the advisory board will review all AEs twice a 
month and where necessary to determine any appro-
priate action in respect of ongoing trial conduct. On 
the informed consent form, information is included to 
inform participants that the research coordinator, inde-
pendent assessor, or another clinician other than their 
PM+ provider are available to them if they are upset by 
this study. The principal investigator will inform the par-
ticipants and the IRB if any adverse event takes place, on 
the basis of which it appears that the disadvantages of 
participation may be significantly greater than was fore-
seen in the research proposal.
Discussion
Estimated deficit of trained health care workers globally 
is around 4 million; factors such as migration and brain 
drain phenomenon further aggravate the situation in 
low resource settings [45]. Task shifting is an established 
implementation strategy to bridge the treatment gap due 
to lack of specialist human resource in low resource set-
tings. Task shifting strategies empower frontline workers 
such as nurses and non-specialist providers to perform 
specific roles to bridge the treatment gap, sustain and 
scale-up care for priority health conditions [46].
Primary health care and community based trials of psy-
chological interventions in LMICs have furnished evi-
dence for the effectiveness of task shifting approach in 
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global mental health [10, 11, 17, 47–49]. This is a unique 
study to evaluate the effectiveness and cost effectiveness 
of integrating task shifting approach in the provision of 
evidence based psychological therapy in a specialised 
mental health care setting of Pakistan.
Specialized mental health care facilities are the main 
source of care for mental health in LMICs, however, 
availability of evidence based psychological interventions 
even in specialised mental health care facilities remain a 
challenge in such settings [6]. In many low resource set-
tings, where there are not enough psychiatrists; trainee 
psychiatrists, psychologists, psychiatric nurses, social 
workers and community based voluntary agents play an 
important role in the provision of care for mental health. 
In many of these settings training opportunities in spe-
cialised, safe and effective psychological interventions are 
not always available. Training in a brief trans-diagnostic 
psychological intervention programme, endorsed by the 
WHO, such as PM+, is envisioned to increase the provi-
sion of safe and effective care for mental health by non-
specialist under the supervision of specialists to bridge 
the treatment gap for mental health care in low resource 
settings.
Evaluating the implementation, effectiveness and cost-
effectiveness of integrating PM+ in routine care services 
will generate evidence to improve access of psychological 
interventions in low resource settings and will serve as a 
model of integrating non-specialist delivered, evidence 
based, cost-effective psychological interventions for com-
mon metal disorders in specialized healthcare settings 
globally.
Trial status
At the time of manuscript submission, trial was ongoing. 
Results of this study are expected early 2017.
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